The authors report preliminary findings from an ongoing prospective
study of neuroleptic-naive patients with first-break schizophrenia. They
evaluated 17 of these patients and 15 normal subjects with a structured
neurological examination before the patients received any medical
treatment. The patients with schizophrenia showed significantly greater
neurological impairment than did the normal comparison subjects.